Skip to main content
. 2022 Feb 2;15:267–286. doi: 10.2147/JPR.S340968

Figure 3.

Figure 3

Continue.

Figure 3.

Figure 3

Relative (percent) change from baseline in ASR-9 composite score and individual components for (A) Nabiximols (Cohort A); (B) Dronabinol (Cohort B); (C) Difference between cohorts A-B in improvement from baseline; (D) Effect size (Cohen’s d) of between-cohort differences A-B in improvement from baseline.

Abbreviations: ASR-9, 9-Factor Aggregated Symptom Relief; DASS, Depression (-D), Anxiety (-A), Stress (-S) Scale; MFHW, Marburg questionnaire on habitual health findings; mPDI, modified pain disability index; PDQ7, 7-item painDETECT questionnaire; PIX, pain intensity index; VR12-MH, Veterans RAND 12-Item Health Survey mental component score; VR12-PH, Veterans RAND 12-Item Health Survey physical component score; W, week.